N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141222 |
| CAS No | NA |
| Mol.F. | C17H19N7O2 |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141223 |
| CAS No | NA |
| Mol.F. | C25H29F3N4O4 |
| Mol.Wt. | 506.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141224 |
| CAS No | NA |
| Mol.F. | C32H33F3N4O5 |
| Mol.Wt. | 610.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141225 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141226 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141227 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141228 |
| CAS No | NA |
| Mol.F. | C13H21N5O2S |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141229 |
| CAS No | NA |
| Mol.F. | C20H30N8O2S2 |
| Mol.Wt. | 478.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141230 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141231 |
| CAS No | NA |
| Mol.F. | C10H16N4OS |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141232 |
| CAS No | NA |
| Mol.F. | C17H13N5O3 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141233 |
| CAS No | NA |
| Mol.F. | C9H9N3O2 |
| Mol.Wt. | 191.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141234 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141235 |
| CAS No | NA |
| Mol.F. | C26H23N5O5 |
| Mol.Wt. | 485.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141236 |
| CAS No | NA |
| Mol.F. | C27H19F3N8O2 : HCl |
| Mol.Wt. | 544.5 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141237 |
| CAS No | NA |
| Mol.F. | C19H17N5O3 |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |